Receiving monoclonal antibodies to treat COVID-19 used to be a time-consuming process at the UPMC Hamot Infusion Center. The intravenous treatment took about 30 minutes, which came after a nearly hour ...

Monoclonal antibodies, the drug cocktail used to treat patients infected with COVID-19, have proven to be an invaluable tool to limit severe disease and hospitalizations since the U.S. Food and Drug ...

Early studies hint that a nerve block in the neck could help restore long COVID patients' sense of smell, but more research is needed. When you purchase through links on our site, we may earn an ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND, Ohio (KFOR/Storyful) – Desperate ...

(RTTNews) - Foster City, California-based Gilead Sciences, Inc. is recalling one lot of Veklury (remdesivir) for Injection 100 mg/vial for treating COVID-19, to the consumer level, due to the presence ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Most patients with wet age-related macular degeneration were able to quickly resume treatment ...

In a recent study posted to the bioRxiv* server, researchers at the United States Army Medical Research Institute of Infectious Diseases evaluated the immunogenicity of a severe acute respiratory ...

They trust the vaccine. They want the vaccine. But millions of U.S. residents who pass out or beat feet at the sight of a hypodermic needle are risking COVID rather than getting a shot in the arm.